| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |